|
|
|
|
|
|
|
|
|
|
Breast (101160)
Sponsor: ACOSOG (Z0131)
|
By Breast on
5/10/2008 10:00 AM
|
|
|
A Randomized Phase III Trial Comparing 16 to 18 Weeks of Neoadjuvant Exemestane (25 mg daily), Letrozole (2.5 mg), or Anastrozole (1 mg) in Postmenopausal Women with Clinical Stage II and III Estrogen Receptor Positive Breast Cancer
None Available
|
 |
|
|
More...
|
|
|
|
|
|
Breast (101203)
Sponsor: CTSU/ECOG (E5103)
|
By Breast on
5/10/2008 10:00 AM
|
|
|
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide
followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
None Available
|
|
|
|
|
More...
|
|